SATB1 loss leads to increased chemokine receptors including CCR4, affecting T-cell migration with the transformation of CD8+ T cells into CD4+CD8+ double-positive T cells and more infiltration of CD3+ T cells in the skin of the mice, and CTCL progression. Here, CD4 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.